Programs
Laboratories and Research Programs
Laboratories and research programs within the UCLA Division of Hematology-Oncology produce groundbreaking science that has dramatically changed the field’s understanding of cancer and led to new treatments that have saved millions of lives.
Explore the pages below to learn more about our cores and laboratories.
Centers
Parker Institute for Cancer Immunotherapy (PICI)
A research community within UCLA that connects researchers who are developing new treatments that expand the cancer immunotherapy options oncologists can offer to help their patients live many more years without cancer progression.
Cores
Flow Cytometry Core
Humanized Mouse Core
Laboratories
Garon Lab
Lee Lab
Morizono Lab
O’Brien Laboratory
Pietras/Márquez-Garbán Lab
Ribas Lab
Sedrak Lab
Seet Lab
Translational Oncology Research Laboratory (TORL)
Spellman Lab
Timmerman Lab
Programs
Cell Therapy Program
The UCLA Center for advanced Biotherapies (CAB) provides comprehensive support for the manufacturing of cell and gene therapy products intended for early-phase clinical trials conducted under FDA Investigational New Drug (IND) applications led by our members, as well as academic and industry collaborators.
UCLA Hematology-Oncology Fellowship Program
The Hematology-Oncology Fellowship Program provides trainees with the necessary skills to become astute clinicians, educators, and future leaders in clinical, health policy, or basic sciences and translational research.
UCLA Immune Effector Cell (IEC) Therapy Program
The multidisciplinary clinical program administers all commercially available IEC products and participated in many of the trials that led to the FDA approvals. The IEC clinical trial team provides clinical trial options for patients with hematologic malignancies, solid tumors, rheumatologic disorders, and myasthenia gravis.